We observed that CD248 + mr-CAFs were far from the tumor cells in naïve tissues but lined the tumor nests in treated tumor tissues, providing a physical barrier to protect malignant tumor cells from immune infiltration and drug delivery (Fig. 4G). This evidence concerns the gene CD248 and neoplasm.